Recruiting PHASE4 Vaccine Preventable Disease

New treatment option for Vaccine Preventable Disease

Official title Measles and BCG Vaccines for Mother and Child

ClinicalTrials.gov ID: NCT04899765

What this study is testing

What is BCG vaccine?

BCG vaccine is an investigational medicine, given as a monthly injection under the skin, being studied as a potential treatment for vaccine preventable disease.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
In Africa, the mortality from infectious diseases remains high. The investigators have discovered that live vaccines such as the BCG vaccine against tuberculosis and the measles vaccine can strengthen resistance to other infections: they have beneficial "non-specific effects".
  • Phase 4: studies an already-approved treatment
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 15 to 35, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Female women in the fertile age
  • Non-pregnant
  • HIV-negative
  • Living in the BHP HDSS study area
  • Delivered a child that has reached 12 months of age

You likely can't join if

  • Positive pregnancy test
  • Positive HIV test
  • Tuberculosis (previous or current)
  • Immunodeficiency
  • Cancer within the last 2 years
  • Mid-upper-arm-circumference\<200
See the full eligibility criteria
Who can join
  • Female women in the fertile age
  • Non-pregnant
  • HIV-negative
  • Living in the BHP HDSS study area
  • Delivered a child that has reached 12 months of age
  • Currently not using contraceptives.
What rules you out
  • Positive pregnancy test
  • Positive HIV test
  • Tuberculosis (previous or current)
  • Immunodeficiency
  • Cancer within the last 2 years
  • Mid-upper-arm-circumference\<200
  • Acute ongoing infection

The study team makes the final eligibility decision.

Where it's taking place

  • Bissau, Bissau Codex, Guinea-Bissau

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 15 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bissau, Bissau Codex, Guinea-Bissau. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.